Global stem cell therapy market is estimated to reach USD +145.7 Million by 2021, growing at a CAGR of +11.0% during the forecast period. Growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research and development, identification of new stem cell lines advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential applications and opportunities from emerging regions have been anticipated to raise the hopes of industry players. Allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, and growing number of clinical trials related to allogeneic stem cell therapies.